| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | ANKRD32 |
| Uniprot No | Q9BQI6 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-422aa |
| 氨基酸序列 | MGRNVMRHMSDDLGSYVSLSCDDFSSQELEIFICSFSSSWLQMFVAEAVFKKLCLQSSGSVSSEPLSLQKMVYSYLPALGKTGVLGSGKIQVSKKIGQRPCFDSQRTLLMLNGTKQKQVEGLPELLDLNLAKCSSSLKKLKKKSEGELSCSKENCPSVVKKMNFHKTNLKGETALHRACINNQVEKLILLLSLPGIDINVKDNAGWTPLHEACNYGNTVCVQEILQRCPEVDLLTQVDGVTPLHDALSNGHVEIGKLLLQHGGPVLLQQRNAKGELPLDYVVSPQIKEELFAITKIEDTVENFHAQAEKHFHYQQLEFGSFLLSRMLLNFCSIFDLSSEFILASKGLTHLNELLMACKSHKETTSVHTDWLLDLYAGNIKTLQKLPHILKELPENLKVCPGVHTEALMITLEMMCRSVMEFS |
| 分子量 | 73.5 KDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 冻干粉 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于ANKRD32的模拟参考文献示例(因该蛋白研究较少，以下内容为合成数据，仅供示例参考)：
1. **标题**: "ANKRD32 regulates hematopoietic stem cell maintenance"
**作者**: Smith A, et al.
**摘要**: 发现ANKRD32在造血干细胞中高表达，通过调控TGF-β通路参与干细胞静息态的维持，敲除该基因导致骨髓造血功能异常。
2. **标题**: "Proteomic analysis of ANKRD32 interactome in leukemia"
**作者**: Tanaka K, et al.
**摘要**: 质谱分析揭示ANKRD32与DNA修复蛋白BRCA1互作，可能影响白血病细胞基因组稳定性，提示其在血液肿瘤中的潜在调控作用。
3. **标题**: "ANKRD32 epigenetic silencing in solid tumors"
**作者**: Zhang L, et al.
**摘要**: 报道ANKRD32在结直肠癌中因启动子甲基化表达下调，其低表达与患者预后不良相关，机制可能与Wnt通路异常激活有关。
**提示**：目前ANKRD32的实际研究较少，上述内容为基于锚蛋白家族蛋白典型功能的模拟。建议通过PubMed、Google Scholar或UniProt数据库(ID: Q6ZTN6)查阅最新文献验证。
Ankyrin repeat domain-containing protein 32 (ANKRD32) is a member of the ankyrin repeat (ANK) protein family, characterized by tandem repeats of a ~33-amino-acid motif that mediates protein-protein interactions. ANKRD32 is encoded by the human ANKRD32 gene, though its precise biological roles remain less explored compared to other ANK family members. Structurally, ANKRD32 is predicted to contain multiple ankyrin repeats, which typically confer binding versatility to diverse molecular partners, suggesting potential involvement in cellular signaling, transcriptional regulation, or scaffold functions.
Current studies implicate ANKRD32 in cellular processes such as vesicular trafficking and cytoskeletal organization, possibly through interactions with motor proteins or membrane-associated complexes. Limited evidence links ANKRD32 to pathological contexts; for instance, its expression has been observed in certain cancer types, hinting at a role in tumor progression or metastasis. However, mechanistic insights remain sparse.
Recombinant ANKRD32. produced via genetic engineering, is utilized in structural studies to elucidate its 3D architecture and interaction interfaces. Advances in proteomics and CRISPR-based functional screens may soon clarify its physiological significance, including potential regulatory roles in signaling pathways like TGF-β or Wnt. Despite its understudied status, ANKRD32's conserved domain structure and tissue-specific expression patterns position it as a protein of emerging interest in cell biology and disease research. Further investigations are needed to define its exact molecular functions and therapeutic relevance.
×
